Biosimilar monoclonal antibodies: A Canadian regulatory perspective on the assessment of clinically relevant differences and indication extrapolation (Q38223249)
Jump to navigation
Jump to search
scientific article published on 26 June 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Biosimilar monoclonal antibodies: A Canadian regulatory perspective on the assessment of clinically relevant differences and indication extrapolation |
scientific article published on 26 June 2014 |
Statements
1 reference
Biosimilar monoclonal antibodies: A Canadian regulatory perspective on the assessment of clinically relevant differences and indication extrapolation (English)
1 reference
Bradley J Scott
1 reference
Agnes V Klein
1 reference
Jian Wang
1 reference
26 June 2014
1 reference
1 reference
55 Suppl 3
1 reference
S123-32
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference